SHENG Mei-xiao, JIN Shi, XIONG Pei-hua, JIANG Yan, ZHONG Yu. Therapeutic Effect of Langchuangjing Granule in Treatment of Syndrome of Kidney Deficiency with Damp Toxin in Active Lupus Nephritis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2007, 23(4): 220-223.
Citation: SHENG Mei-xiao, JIN Shi, XIONG Pei-hua, JIANG Yan, ZHONG Yu. Therapeutic Effect of Langchuangjing Granule in Treatment of Syndrome of Kidney Deficiency with Damp Toxin in Active Lupus Nephritis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2007, 23(4): 220-223.

Therapeutic Effect of Langchuangjing Granule in Treatment of Syndrome of Kidney Deficiency with Damp Toxin in Active Lupus Nephritis

More Information
  • Received Date: April 02, 2007
  • OBJECTIVE To observe the effect of the Chinese drug Langchuangjing Granule in the treatment of the syndrome of kidney deficiency with damp toxin in patients with active lupus nephritis(LN).METHOD Forty LN patients were divided into a treatment group of 22 patients(treated with western medicine and Langchuangjing Granule) and a control group of 18 patients(treated with western medicine only) and were treated for 12 weeks.RESULT Good effect was obtained in relieving albuminuria in the patients with a level of <3.5g/24 h after the 8th day,and hematuria and SLEDAI integral started to be reduced markedly since the 4th week,with statistical significance between the two groups(P<0.05).Kidney function was improved.Better effect was obtained in the treatment group in relieving skin red patches,lumbago,palpitation caused by hormone and tremor of the hand (P<0.05).CONCLUSION Based on the immunity inhibition treatment with western medicine,Langchuangjing Granule is effective in controlling the condition of LN,relieving the clinical symptoms,reducing the side effect of western medicines,relieving albuminuria and hematuria,and improving the kidney function.
  • [1]
    Cheigh JS,Kim H.Systemic lupus erythematosus in paitents with end-stage renal disease:Long-term follow-up on the prognosis of patients and the evolution of lupus activity[J].Am J Kidney Dis,1990,16:189.
    [2]
    Hochberg MC.Updating the American College of Rheumatologyrevised criteria for the classification of SLE[J].Arthritis Rheum,1997,40:1725.
    [3]
    Claire Bombardier,Dafna D.Giadman,Murray B.Umwitz et al.Derivation f the SLEDAI[J].Arthrotis and Rheumatism,1997,35(6):630.
    [4]
    邹万忠.肾脏病理与临床[M].长沙:湖南科学技术出版社,1997.55.
    [5]
    郑筱萸.中药新药临床研究指导原则[S].北京:中国医药科技出版社,2002.219.
    [6]
    沈庆法.中医临床肾脏病学[M].上海:上海科学技术文献出版社,1997.452.
    [7]
    中国中西医结合肾病专业委员会.弥漫增生型狼疮肾炎中西医结合诊治标准[S].中国中西医结合肾病杂志,2002,3(4):189.
    [8]
    盛梅笑,王钢,王胜菊.狼疮性肾炎中医证候学特征的临床回顾性分析[J].辽宁中医杂志,2004,31(6):475.
    [9]
    王敏,董怡,黄尚东.肿瘤坏死因子α基因多态性及其与系统性红斑狼疮的相关性[J].中华内科杂志,1999,38(3):393.
    [10]
    蔡后荣,张杏书,刘布骏,等.血清可溶性IL-2R检测在结缔组织病中的应用[J].上海免疫学杂志,1993,13(4):216.
    [11]
    杨利,金实,汪悦,等.狼疮静颗粒对活动性SLE患者血清sIL-2R、TNF-α的影响[J].中国中医药信息杂志,2000,7(9):37.

Catalog

    Article Metrics

    Article views (1429) PDF downloads (0) Cited by()
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return